RE:RE:RE:History of FDA Ruling countdown - EDT ....MM - great observations. I do respect your opinion that the real value on PMX approval is near $10 a share. You've always provided the math to back that up and the methodology is sound.
Now that we're ever so close to the interim of 90 patients and we're exceeding expectations it made sense to again mention the much higher share price valuation from Paradigm Capital as it greatly exceeds the current trading price. Many signs point to attention from the US market including recent meetings there and the fact the convertible debentures are being issued in US dollars. If we do the math on those elements it likely won't be very long that we stay at these low share prices. Rewarding all of us substantive shareholders that have been here for many years. Looking forward to success in the near term and the reward we've earned from our years of patient investing.